S G Chrysant|M Cohen - JoVE Visualize

Showing results (61-70 of 5,803) with videos related to

Pageof 581

Sort By:

Journal of Human Hypertension|March 5, 2010

Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trialS Oparil, S G Chrysant, M Melino, et al.

American Journal of Hypertension|March 1, 1989

Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertensionS P Glasser, S G Chrysant, J Graves, et al.

Journal of Clinical Pharmacology|April 29, 1998

Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension GroupS G Chrysant, H Gavras, A L Niederman, et al.

Postgraduate Medical Journal|January 1, 1979

Antihypertensive and renal effects of tienilic acidE D Frohlich, J G De Carvalho, F G Dunn, et al.

Journal of Cardiovascular Pharmacology|January 1, 1980

Systemic and renal hemodynamic effects of trimazosin: a new vasodilatorS G Chrysant, T M Luu, K Danisa, et al.

Clinical Cardiology|June 1, 1997

Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CDB M Massie, S G Chrysant, A Jain, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 21, 1998

Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertensionH Gavras, S G Chrysant, A L Niederman, et al.

Clinical Pharmacology and Therapeutics|April 1, 1993

Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study GroupS G Chrysant, R H McDonald, J T Wright, et al.

Archives of Internal Medicine|December 1, 1977

Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differencesS G Chrysant, F G Dunn, J G De Carvalho, et al.

American Heart Journal|January 8, 1999

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators GroupJ M Neutel, V Buckalew, S G Chrysant, et al.

Pageof 581

Showing results (61-70 of 5,803) with videos related to

Sort By:

Pageof 581

Journal of Human Hypertension|March 5, 2010

Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trialS Oparil, S G Chrysant, M Melino, et al.

American Journal of Hypertension|March 1, 1989

Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertensionS P Glasser, S G Chrysant, J Graves, et al.

Journal of Clinical Pharmacology|April 29, 1998

Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension GroupS G Chrysant, H Gavras, A L Niederman, et al.

Postgraduate Medical Journal|January 1, 1979

Antihypertensive and renal effects of tienilic acidE D Frohlich, J G De Carvalho, F G Dunn, et al.

Journal of Cardiovascular Pharmacology|January 1, 1980

Systemic and renal hemodynamic effects of trimazosin: a new vasodilatorS G Chrysant, T M Luu, K Danisa, et al.

Clinical Cardiology|June 1, 1997

Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CDB M Massie, S G Chrysant, A Jain, et al.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)|March 21, 1998

Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertensionH Gavras, S G Chrysant, A L Niederman, et al.

Clinical Pharmacology and Therapeutics|April 1, 1993

Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study GroupS G Chrysant, R H McDonald, J T Wright, et al.

Archives of Internal Medicine|December 1, 1977

Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differencesS G Chrysant, F G Dunn, J G De Carvalho, et al.

American Heart Journal|January 8, 1999

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators GroupJ M Neutel, V Buckalew, S G Chrysant, et al.

Pageof 581